Opening book details…
About this Medicine article
1052P Genetic modification of Iovance’s TIL through TALEN-mediated knockout of PD-1 as a strategy to empower TIL therapy for cancer by K. Ritthipichai; M. Machin; A. Juillerat; L. Poirot; M. Fardis; C. Chartier is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- K. Ritthipichai; M. Machin; A. Juillerat; L. Poirot; M. Fardis; C. Chartier
- Publisher
- Oxford University Press; Elsevier BV (ISSN 0923-7534)
- Published
- 2020
- Language
- EN
- Field
- Medicine (Health Sciences)
More by K. Ritthipichai; M. Machin; A. Juillerat; L. Poirot; M. Fardis; C. Chartier
Browse all works by K. Ritthipichai; M. Machin; A. Juillerat; L. Poirot; M. Fardis; C. Chartier